Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Novel therapies for severe asthma in children and adults.

Delimpoura V, Bostantzoglou C, Liu N, Nenna R.

Breathe (Sheff). 2018 Mar;14(1):59-62. doi: 10.1183/20734735.018917. Erratum in: Breathe (Sheff). 2018 Jun;14 (2):165.

2.

Clinical asthma phenotypes in the real world: opportunities and challenges.

Bostantzoglou C, Delimpoura V, Samitas K, Zervas E, Kanniess F, Gaga M.

Breathe (Sheff). 2015 Sep;11(3):186-93. doi: 10.1183/20734735.008115. Review.

3.

Anti-IgE treatment, airway inflammation and remodelling in severe allergic asthma: current knowledge and future perspectives.

Samitas K, Delimpoura V, Zervas E, Gaga M.

Eur Respir Rev. 2015 Dec;24(138):594-601. doi: 10.1183/16000617.00001715. Review.

4.

Concurrent granulomatous hepatitis, pneumonitis and sepsis as a complication of intravesical BCG immunotherapy.

Delimpoura V, Samitas K, Vamvakaris I, Zervas E, Gaga M.

BMJ Case Rep. 2013 Oct 10;2013. pii: bcr2013200624. doi: 10.1136/bcr-2013-200624.

5.

Levels of angiopoietins 1 and 2 in induced sputum supernatant in patients with COPD.

Bessa V, Loukides S, Hillas G, Delimpoura V, Simoes D, Kontogianni K, Papiris S, Kostikas K, Alchanatis M, Bakakos P.

Cytokine. 2012 Jun;58(3):455-60. doi: 10.1016/j.cyto.2012.03.007. Epub 2012 Apr 6.

PMID:
22483377
6.

Increased levels of osteopontin in sputum supernatant in severe refractory asthma.

Delimpoura V, Bakakos P, Tseliou E, Bessa V, Hillas G, Simoes DC, Papiris S, Loukides S.

Thorax. 2010 Sep;65(9):782-6. doi: 10.1136/thx.2010.138552.

PMID:
20805171
7.

Exhaled nitric oxide and exhaled breath condensate pH in severe refractory asthma.

Tseliou E, Bessa V, Hillas G, Delimpoura V, Papadaki G, Roussos C, Papiris S, Bakakos P, Loukides S.

Chest. 2010 Jul;138(1):107-13. doi: 10.1378/chest.09-1257. Epub 2010 Feb 19.

PMID:
20173051

Supplemental Content

Loading ...
Support Center